According to a consensus statement of the US CurePSP Centers of Care [250], the following managements of CI in PSP/CBS are recommended: Pharmacological treatment includes cholinesterase, such as donepezil that should be discontinued if no benefit is observed. This evidence concerns the gene BCHE and supranuclear palsy, progressive, 1.